Demyelinating Autoimmune Diseases, CNS
"Demyelinating Autoimmune Diseases, CNS" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions characterized by loss or dysfunction of myelin (see MYELIN SHEATH) in the brain, spinal cord, or optic nerves secondary to autoimmune mediated processes. This may take the form of a humoral or cellular immune response directed toward myelin or OLIGODENDROGLIA associated autoantigens.
| Descriptor ID |
D020278
|
| MeSH Number(s) |
C10.114.375 C10.228.140.695.562 C10.314.350 C20.111.258.250
|
| Concept/Terms |
Demyelinating Autoimmune Diseases, CNS- Demyelinating Autoimmune Diseases, CNS
- Demyelinating Autoimmune Disorders, CNS
- Demyelinating Disease, Autoimmune, CNS
- CNS Demyelinating Autoimmune Diseases
- Autoimmune Demyelinating Diseases, CNS
- Autoimmune Demyelinating Disorders, CNS
- CNS Autoimmune Demyelinating Disorders
- Demyelinating Autoimmune Diseases, Central Nervous System
- Autoimmune Demyelinating Diseases, Central Nervous System
|
Below are MeSH descriptors whose meaning is more general than "Demyelinating Autoimmune Diseases, CNS".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Autoimmune Diseases, CNS".
This graph shows the total number of publications written about "Demyelinating Autoimmune Diseases, CNS" by people in this website by year, and whether "Demyelinating Autoimmune Diseases, CNS" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Demyelinating Autoimmune Diseases, CNS" by people in Profiles.
-
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024 Jul; 87:105672.
-
Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2022 03; 9(2).
-
Qki is an essential regulator of microglial phagocytosis in demyelination. J Exp Med. 2021 01 04; 218(1).
-
Health-Related Quality of Life in Pediatric Patients With Demyelinating Diseases: Relevance of Disability, Relapsing Presentation, and Fatigue. J Pediatr Psychol. 2018 03 01; 43(2):133-142.
-
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology. 2016 Jan 19; 86(3):245-52.